NEW YORK (GenomeWeb) – Lucigen has raised $2.2 million in a private financing round, its CEO confirmed to GenomeWeb today.

The Middleton, Wisc.-based firm disclosed the financing in a regulatory document filed with the US Securities and Exchange Commission this week. In an email, Lucigen Chairman and CEO Ralph Kauten said that the financing is an extension of a private stock placement completed in January that brought in $2 million. According to this week's SEC document, Lucigen is targeting $2.5 million in the round in total.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.